NCT06126198Completed
RTMS Feasibility Study on Adolescent Depression Stimulation
1 Hz RTMS Feasibility Study on Adolescent Treatment Resistant Major Depression
Source: ClinicalTrials.gov · Last updated 4 Feb 2025
Brief summary (registry, in English)
This is an open-label study, in which all participants receives an active treatment with repetitive transcranial magnetic stimulation (rTMS) according to clinical protocol. The aim with this pilotstudy is to investigate the feasibility to perform a trial of low-frequency rTMS on treatment-resistant depression in adolescents. The study includes adolescents 13-19 years old, with average to severe depression.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 3 Nov 2023
- Start date
- 1 Jan 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Uppsala University
- Diseases
- Depression, Bipolar disorder
- NCT number
- NCT06126198
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 1 Jan 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Implanted medication pumps
- Treatment with any medication that could lower the threshold for seizures
- Usage of benzodiazepines both as prescribed drug and illegal use
Other illness
- Epilepsy or medical history of seizures
- Active substance use disorder
- Any condition that seriously increases the risk of non-compliance or loss of follow-up
Other
- Conductive ferromagnetic or other magnetic sensitive metals implanted in the head or within 30 cm of the treatment coil
- Implanted device that is activated or controlled in any way by physiological signals
- Intracardiac lines (even if removed)
Who the study is looking for
- Informed consent from parents and legal guardian
- Age 13-19 years
- Diagnosis of uni- or bipolar depression verified through a Mini International Neuropsychiatric Interview for children and adolescents (MINI-KID)
- Treatment with at least two SSRIs at an adequate dose for at least 8 weeks
Age in the registry: 13 years to 19 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uppsala University Coordinator of this site? Confirm its status | Uppsala | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.